Details
Stereochemistry | ACHIRAL |
Molecular Formula | C25H27N9.2BrH.2H2O |
Molecular Weight | 651.397 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
Stereo Comments | Substituted ring |
SHOW SMILES / InChI
SMILES
O.O.Br.Br.CN1N=NC(=N1)C2=CC3=C(C=C2)C4=C(N[C@H]5CC[C@H](N)CC5)N=C(CC6=CC=CC=C6)N=C4N3
InChI
InChIKey=LTZREELAANPAIQ-ZCPXLSQTSA-N
InChI=1S/C25H27N9.2BrH.2H2O/c1-34-32-23(31-33-34)16-7-12-19-20(14-16)28-25-22(19)24(27-18-10-8-17(26)9-11-18)29-21(30-25)13-15-5-3-2-4-6-15;;;;/h2-7,12,14,17-18H,8-11,13,26H2,1H3,(H2,27,28,29,30);2*1H;2*1H2/t17-,18-;;;;
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/25237102Curator's Comment: description was created based on several sources, including
http://www.google.com/patents/WO2013110198A1 | https://www.ncbi.nlm.nih.gov/pubmed/28330619 | https://www.ncbi.nlm.nih.gov/pubmed/27337543 | https://clinicaltrials.gov/ct2/show/study/NCT02668315
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25237102
Curator's Comment: description was created based on several sources, including
http://www.google.com/patents/WO2013110198A1 | https://www.ncbi.nlm.nih.gov/pubmed/28330619 | https://www.ncbi.nlm.nih.gov/pubmed/27337543 | https://clinicaltrials.gov/ct2/show/study/NCT02668315
UM171 is a potent agonist of human hematopoietic stem cell renewal, independently of AhR suppression. UM171 act differently than other small molecule stimulators of hematopoiesis, such as the aryl hydrocarbon receptor (AhR) antagonist StemRegenin 1 (SR1). Addition of UM171 to cultures containing SR1 and cytokines further enhances the ex vivo expansion of normal HSCs, including CD34+ cells.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: WP2849 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27337543 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25237102
CD34+ cells isolated from cord blood (CB) were cultured in a fed-batch (FB) system for 12 days in the presence of cytokines and UM171 [35 nM], SR1 [750 nM] or the combination of both UM171 [35 nM] and SR1 [500 nM].
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
661418
Created by
admin on Sat Dec 16 14:24:57 GMT 2023 , Edited by admin on Sat Dec 16 14:24:57 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9VB5UBJ45H
Created by
admin on Sat Dec 16 14:24:57 GMT 2023 , Edited by admin on Sat Dec 16 14:24:57 GMT 2023
|
PRIMARY | |||
|
300000009940
Created by
admin on Sat Dec 16 14:24:57 GMT 2023 , Edited by admin on Sat Dec 16 14:24:57 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD